The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
Authors
Keywords
SARS-CoV-2, COVID-19, Inflammation, Cytokines
Journal
MICROBIAL PATHOGENESIS
Volume 153, Issue -, Pages 104799
Publisher
Elsevier BV
Online
2021-02-19
DOI
10.1016/j.micpath.2021.104799
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
- (2020) Jasper Fuk-Woo Chan et al. LANCET
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV
- (2020) Jiabao Xu et al. Viruses-Basel
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
- (2020) Yajing Fu et al. VIROLOGICA SINICA
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
- (2020) Huan Han et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
- (2020) Francesca Coperchini et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Covid-19 infection in Crohn’s disease under treatment with adalimumab
- (2020) Antonio Tursi et al. GUT
- A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis
- (2020) Stefano Mazza et al. GUT
- New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
- (2020) Christian A. Devaux et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
- (2020) Chi Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
- (2020) Tobias Herold et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- COVID-19 spike-host cell receptor GRP78 binding site prediction
- (2020) Ibrahim M. Ibrahim et al. JOURNAL OF INFECTION
- Tocilizumab for the treatment of severe coronavirus disease 2019
- (2020) Rand Alattar et al. JOURNAL OF MEDICAL VIROLOGY
- TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
- (2020) Dandan Wu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19
- (2020) Marisa Dolhnikoff et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- COVID-19 cytokine storm: the interplay between inflammation and coagulation
- (2020) Ricardo J Jose et al. Lancet Respiratory Medicine
- Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19
- (2020) Adnan Shah Frontiers in Immunology
- Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
- (2020) Jean-Michel Sallenave et al. Frontiers in Immunology
- Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Bo Diao et al. Frontiers in Immunology
- The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response
- (2020) Fernanda I Arnaldez et al. Journal for ImmunoTherapy of Cancer
- Molecular immune pathogenesis and diagnosis of COVID-19
- (2020) Xiaowei Li et al. Journal of Pharmaceutical Analysis
- A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections
- (2020) Marika Orlov et al. JOURNAL OF IMMUNOLOGY
- COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis
- (2020) Robert Lorenz Chua et al. NATURE BIOTECHNOLOGY
- Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway
- (2020) Qinhai Ma et al. PHYTOMEDICINE
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
- (2020) Yujun Tang et al. Frontiers in Immunology
- Coagulation and anticoagulation in COVID-19
- (2020) Tarik Hadid et al. BLOOD REVIEWS
- Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19
- (2020) Younes Zaid et al. CIRCULATION RESEARCH
- The different faces of the NLRP3 inflammasome in cutaneous Leishmaniasis: A review
- (2020) Ayyoub Kihel et al. CYTOKINE
- Mitochondria and microbiota dysfunction in COVID-19 pathogenesis
- (2020) Jumana Saleh et al. MITOCHONDRION
- IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome
- (2020) Sujin Kang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases
- (2020) Abdullah Mahmud-Al-Rafat et al. CYTOKINE
- Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
- (2019) I-Yin Chen et al. Frontiers in Microbiology
- Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC
- (2019) Kam-Leung Siu et al. FASEB JOURNAL
- RNA viruses promote activation of the NLRP3 inflammasome through cytopathogenic effect-induced potassium efflux
- (2019) Leandro Silva da Costa et al. Cell Death & Disease
- IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
- (2019) Rudragouda Channappanavar et al. JOURNAL OF CLINICAL INVESTIGATION
- MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
- (2018) Waleed H. Mahallawi et al. CYTOKINE
- Middle East respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells
- (2018) Hin Chu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MERS, SARS and other coronaviruses as causes of pneumonia
- (2017) Yudong Yin et al. RESPIROLOGY
- Type I Interferons as Regulators of Lung Inflammation
- (2017) Spyridon Makris et al. Frontiers in Immunology
- SARS and MERS: recent insights into emerging coronaviruses
- (2016) Emmie de Wit et al. NATURE REVIEWS MICROBIOLOGY
- Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity
- (2016) Janette Bester et al. Scientific Reports
- Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome
- (2015) Jose L. Nieto-Torres et al. VIROLOGY
- Interleukin-6 (IL-6) and IL-17 Synergistically Promote Viral Persistence by Inhibiting Cellular Apoptosis and Cytotoxic T Cell Function
- (2014) W. Hou et al. JOURNAL OF VIROLOGY
- IL-6 in Inflammation, Immunity, and Disease
- (2014) T. Tanaka et al. Cold Spring Harbor Perspectives in Biology
- Cytokine synergy: An underappreciated contributor to innate anti-viral immunity
- (2013) Eric Bartee et al. CYTOKINE
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- Combination of IL-17 and TNFα induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells
- (2012) Arnaud Hot et al. ANNALS OF THE RHEUMATIC DISEASES
- TNF-α-induces airway hyperresponsiveness to cholinergic stimulation in guinea pig airways
- (2011) R Makwana et al. BRITISH JOURNAL OF PHARMACOLOGY
- IL-17 Boosts Proinflammatory Outcome of Antiviral Response in Human Cells
- (2011) Grigory Ryzhakov et al. JOURNAL OF IMMUNOLOGY
- Immunological and Inflammatory Functions of the Interleukin-1 Family
- (2009) Charles A. Dinarello Annual Review of Immunology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now